Pharma Overuse Data examines the critical issue of pharmaceutical overuse in the United States, a growing public health concern fueled by regulatory failures and aggressive industry practices. The book presents a data-driven analysis of trends in prescription and consumption of commonly overused medications, such as opioids and antibiotics, highlighting how this overuse jeopardizes individual health and strains healthcare systems. Notably, the rise in antibiotic resistance, a direct consequence of overuse, poses a significant threat to global health security. The book uniquely combines statistical analysis with policy examination to reveal systemic weaknesses in medication regulation and the impact of pharmaceutical marketing. It begins by establishing foundational concepts before analyzing data from prescription databases to reveal overuse trends. It then critically evaluates regulatory policies and investigates the impact of industry lobbying. By connecting public health, political science, and healthcare economics themes, it is valuable to policymakers, healthcare professionals, and informed citizens. Through its evidence-based approach, relying on data from government agencies and industry reports, Pharma Overuse Data offers actionable insights. The book progresses from foundational concepts to data analysis, policy evaluation, and industry scrutiny, concluding with evidence-based policy recommendations and practical strategies for mitigating medication overuse. This comprehensive examination offers a unique perspective on the intersection of public health and politics in the pharmaceutical landscape.
